Shripad Banavali - Concepedia

Author

Shripad Banavali

Also Known As

Banavali, Shripad, S Banavali, S D Banavali, S. Banavali, S. D Banavali, S. D. Banavali, S.D Banavali, S.D. Banavali, SHRIPAD BANAVALI, Shripad Banavali

286

Publications

6.2K

Citations

H-Index

115

Concepts

All Affiliations

Tata Memorial Hospital Homi Bhabha National Institute Advanced Centre for Treatment, Research and Education in Cancer All India Institute of Medical Sciences

About

Shripad Banavali is an author at Tata Memorial Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	33	2.1K
2	Health Sciences	6	6	196
3	Nursing	4	4	102
4	Arts	1	1	12
5	Education	1	1	27

Shripad Banavali

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
ecancermedicalscience Gauthier Bouche, Nicolás André, Shripad Banavali, ecancermedicalscience Neuro-oncologyChemoprevention StrategyMedicineFourth MetronomicMetronomic Therapy	2016	678
Challenges to effective cancer control in China, India, and Russia Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky, The Lancet Oncology MedicineGlobal HealthCancer ManagementCancer PreventionBreast Cancer	2014	497
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer Vanita Noronha, Vijay Patil, Amit Joshi, Journal of Clinical Oncology	2019	415
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial Vanita Noronha, Amit Joshi, Vijay Patil, Journal of Clinical Oncology	2017	326
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study Vijay Patil, Vanita Noronha, Nandini Menon, Journal of Clinical Oncology	2022	181
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer Vijay Patil, Vanita Noronha, Amit Joshi, Cancer	2019	127
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study Eddy Pasquier, Nicolás André, Janine Street, EBioMedicine	2016	118
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial Vijay Patil, Vanita Noronha, Sachin Dhumal, The Lancet Global Health	2020	98
Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas. Jeffrey A. Meyerhardt, K Caca, B C Eckstrand, PubMed Tumor BiologyDevelopmental BiologyMedicineCancer Cell BiologyPathology	1999	92
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck Vijay Patil, Vanita Noronha, Amit Joshi, Oral Oncology MedicineMetronomic TherapyPhase Ii StudyHead And Neck CancerHead And Neck Surgery	2015	85

Page 1